10.1371/journal.pone.0219142.t003 Yehuda Z. Cohen Yehuda Z. Cohen Allison L. Butler Allison L. Butler Katrina Millard Katrina Millard Maggi Witmer-Pack Maggi Witmer-Pack Rebeka Levin Rebeka Levin Cecilia Unson-O’Brien Cecilia Unson-O’Brien Roshni Patel Roshni Patel Irina Shimeliovich Irina Shimeliovich Julio C. C. Lorenzi Julio C. C. Lorenzi Jill Horowitz Jill Horowitz Stephen R. Walsh Stephen R. Walsh Shu Lin Shu Lin Joshua A. Weiner Joshua A. Weiner Anna Tse Anna Tse Alicia Sato Alicia Sato Chelsey Bennett Chelsey Bennett Bryan Mayer Bryan Mayer Kelly E. Seaton Kelly E. Seaton Nicole L. Yates Nicole L. Yates Lindsey R. Baden Lindsey R. Baden Allan C. deCamp Allan C. deCamp Margaret E. Ackerman Margaret E. Ackerman Michael S. Seaman Michael S. Seaman Georgia D. Tomaras Georgia D. Tomaras Michel C. Nussenzweig Michel C. Nussenzweig Marina Caskey Marina Caskey Pharmacokinetic parameters of 3BNC117 and 10–1074 administered in combination. Public Library of Science 2019 3 BNC 117 combination antibodies 3 BNC 117 number NCT 02824536. Findings target non-overlapping epitopes phase 1 study Anti-drug antibody responses infusion phase 1 study Background neutralizing anti-HIV pre-exposure prophylaxis 2019-08-08 17:33:45 Dataset https://plos.figshare.com/articles/dataset/Pharmacokinetic_parameters_of_3BNC117_and_10_1074_administered_in_combination_/9391604 <p>Pharmacokinetic parameters of 3BNC117 and 10–1074 administered in combination.</p>